{
  "docId": "019de514-c6ee-70fe-9ed1-115332e66453",
  "docSlug": "7d8148a830366811cd98c46e453c2fa7",
  "documentTitle": "Adagio Therapeutics | Investor Conference Presentation Deck | 10 slides",
  "authorId": "adagio-therapeutics",
  "authorName": "Invivyd",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 10,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-c6ee-70fe-9ed1-115332e66453/6",
  "deckHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453",
  "deckJsonHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453.json",
  "deckAnchorHref": "/decks/019de514-c6ee-70fe-9ed1-115332e66453#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.016,
        "w": 0.74,
        "x": 0.045,
        "y": 0.855
      },
      "kind": "source-note",
      "text": "Investigational therapies are not approved for use by regulatory authorities. The safety and efficacy of pipeline candidates have not been established.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e7947d0-823c-4a64-b81b-404b5624e7c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.57,
        "w": 0.91,
        "x": 0.045,
        "y": 0.256
      },
      "kind": "table",
      "text": "PROGRAMS, PLATFORM, INDICATION(S), DEVELOPMENT STATUS (DISCOVERY, IND-ENABLING, PHASE 1, PHASE 2, PHASE 3), STATUS for Coronavirus (NVD200, COVID Candidate #2, COVID Candidate #3, Adintrevimab) and Other Viruses (Influenza).",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e13ca7ae-cdeb-4c53-a163-ce9663badc6f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.899,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "ROBUST PIPELINE OF ANTIBODIES FOR TREATMENT AND PREVENTION OF VIRAL DISEASES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a1e1403f-bb8a-4f12-b03a-b4594cde9709",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "00952765-7bb9-4952-a9c4-ba7a4b51952f",
      "evidence": "table/data: PROGRAMS, PLATFORM, INDICATION(S), DEVELOPMENT STATUS (DISCOVERY, IND-ENABLING, PHASE 1, PHASE 2, PHASE 3), STATUS",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "8f586047-fdbe-4793-9641-0c1f5c37eadc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation of Invivyd's combination approach and pipeline of antibodies",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ebd5e9d0-7739-45d1-9c72-3cc4af38795c",
      "evidence": "The presentation of Invivyd's combination approach and pipeline of antibodies",
      "position": 1,
      "objective": "Why is Invivyd's approach effective in developing COVID-19 product candidates?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}